COLL
Collegium Pharmaceutical Inc

1,584
Mkt Cap
$1.49B
Volume
339,067.00
52W High
$48.18
52W Low
$23.23
PE Ratio
28.62
COLL Fundamentals
Price
$45.98
Prev Close
$46.38
Open
$46.20
50D MA
$36.36
Beta
0.63
Avg. Volume
316,604.17
EPS (Annual)
$1.86
P/B
5.29
Rev/Employee
$1.77M
Loading...
Loading...
News
all
press releases
Campbell & CO Investment Adviser LLC Cuts Stake in Collegium Pharmaceutical, Inc. $COLL
Campbell & CO Investment Adviser LLC lessened its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 18.5% in the 2nd quarter, according to the company in its most...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month High - Here's Why
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 12-Month High - Still a Buy...
MarketBeat·3d ago
News Placeholder
Collegium Pharmaceutical (NASDAQ:COLL) Announces Quarterly Earnings Results
Collegium Pharmaceutical (NASDAQ:COLL - Get Free Report) released its quarterly earnings data on Thursday. The specialty pharmaceutical company reported $2.25 EPS for the quarter, beating analysts...
MarketBeat·6d ago
News Placeholder
Truist Financial Issues Positive Forecast for Collegium Pharmaceutical (NASDAQ:COLL) Stock Price
Truist Financial upped their price objective on shares of Collegium Pharmaceutical from $45.00 to $48.00 and gave the stock a "buy" rating in a report on Friday...
MarketBeat·8d ago
News Placeholder
HC Wainwright Raises Collegium Pharmaceutical (NASDAQ:COLL) Price Target to $46.00
HC Wainwright increased their price target on shares of Collegium Pharmaceutical from $44.00 to $46.00 and gave the stock a "buy" rating in a report on Friday...
MarketBeat·8d ago
News Placeholder
Collegium Pharmaceutical (NASDAQ:COLL) CFO Sells $1,215,900.00 in Stock
Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Get Free Report) CFO Colleen Tupper sold 30,000 shares of the firm's stock in a transaction on Thursday, November 6th. The shares were sold at an average...
MarketBeat·8d ago
News Placeholder
Collegium Pharmaceutical (NASDAQ:COLL) Rating Increased to Strong-Buy at Wall Street Zen
Wall Street Zen upgraded shares of Collegium Pharmaceutical from a "buy" rating to a "strong-buy" rating in a research note on Saturday...
MarketBeat·8d ago
News Placeholder
Collegium Pharmaceutical (NASDAQ:COLL) Reaches New 52-Week High - Here's What Happened
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 1-Year High - Time to Buy...
MarketBeat·9d ago
News Placeholder
Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings
The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·10d ago
News Placeholder
Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Beat Estimates
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of +19.68% and +10.35%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago

Latest COLL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.